Hudes, Gary R.
Fox Chase Cancer Center,
United States
2025 Rank: 35764
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 1575 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35764 | 40198 |
| Total Cites | 14885 | 16294 |
| H-index | 52 | 53 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 428 | 444 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 4503 | 4749 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 6033 | 6376 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11590 | 12389 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.32 |
| Self-Citation Percentage |
8.65%
|
|
Hudes, Gary R.
Fox Chase Cancer Center,
United States
2024 Rank: 33263
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 1489 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33263 | 37320 |
| Total Cites | 14574 | 15975 |
| H-index | 51 | 52 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 424 | 440 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 4436 | 4681 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 5904 | 6243 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11303 | 12097 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.32 |
| Self-Citation Percentage |
8.77%
|
|
Hudes, Gary R.
Fox Chase Cancer Center,
United States
2023 Rank: 38954
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 1739 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38954 | 44221 |
| Total Cites | 14249 | 15650 |
| H-index | 50 | 51 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 203 | 209 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 4332 | 4586 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 5753 | 6099 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11016 | 11810 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.33 |
| Self-Citation Percentage |
8.95%
|
|
Hudes, Gary R.
Fox Chase Cancer Center,
United States
2022 Rank: 35738
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 1610 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35738 | 40572 |
| Total Cites | 13778 | 15167 |
| H-index | 50 | 51 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 194 | 200 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 4197 | 4450 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 5526 | 5866 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10595 | 11381 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.33 |
| Self-Citation Percentage |
9.16%
|
|
Hudes, Gary R.
Fox Chase Cancer Center,
United States
2021 Rank: 34347
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 1563 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 34347 | 38855 |
| Total Cites | 13453 | 14817 |
| H-index | 50 | 51 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 186 | 192 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 4083 | 4333 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 5366 | 5702 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10325 | 11097 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.34 |
| Self-Citation Percentage |
9.21%
|
|
Hudes, Gary R.
Fox Chase Cancer Center,
United States
2020 Rank: 32205
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 1539 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32205 | 36278 |
| Total Cites | 12926 | 14253 |
| H-index | 47 | 49 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 179 | 185 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 3939 | 4172 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 5128 | 5440 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9856 | 10603 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.34 |
| Self-Citation Percentage |
9.31%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.